期刊文献+

奥沙利铂联合卡培他滨治疗30例晚期胃癌的疗效探讨 被引量:2

下载PDF
导出
摘要 目的探讨奥沙利铂联合卡培他滨治疗晚期胃癌的临床效果及不良反应。方法对照组采用顺铂+5-氟尿嘧啶+CF化疗方案,观察组采用奥沙利铂+卡培他滨化疗方案,每个化疗周期内均对患者出现的毒副反应进行详细记录,每2个周期评价疗效。结果对照组临床总有效率为26.67%,无一例达到CR,8例PR,11例SD,11例PD,mTTP时间为5个月,MST时间为8个月;观察组临床总有效率为46.67%,1例CR,13例PR,8例SD,8例PD,mTTP时间为6个月,MST时间为10个月。主要毒副反应为腹泻、手足综合征、恶心呕吐、血小板及白细胞减少等,但未影响化疗进程。结论奥沙利铂联合卡培他滨治疗晚期胃癌的疗效较好,患者毒副反应较少且轻,值得推广。
出处 《中外医疗》 2013年第19期118-119,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献4

二级参考文献56

  • 1鄢践.实体瘤疗效评定最新指南[J].国外医学·肿瘤分册,2000,27(6):375-375.
  • 2Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985 [J]. Int J Cancer, 1993,54(4) :594-606.
  • 3Parkin DM, Bray FI, Devesa SS Cancer burden in the year 2000 [J] The global picture. Eur J Cancer, 2001,37(Suppl 8) : S4-S66.
  • 4Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce disparities in different geographic regions of the world [J]. J Clin Oncol, 2006,24(14) :2137-2150.
  • 5Pyrhonen S, Kuitunen T, Nyandoto P, et al. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer [J]. Br J Cancer,1995,71(3):587-591.
  • 6Murad AM, Santiago FF, Petroianu A, et al. Modified therapy with 5- fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer [J]. Cancer, 1993,72(1):37-41.
  • 7Schethauer W, Kornek G, Zeh B. Palliative chemotherapy vs supportive care in patients with metastatic gastric cancer: a randomized trial [C]. Second International Conference on Biology, Prevention and Treatment of Gastrointestinal malignancies. Koln, 1995 : 65.
  • 8Glimelius B, Ekstrom K, Hoffman K, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer [J]. Ann Oncol, 1997, 8(2) : 163-168.
  • 9Wils JA, Klein HO, Wagener DJ, et al. Sequential high-dose methotrexate and fiuorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group [J]. J Clin Oncol, 1991,9(5): 827-831.
  • 10Webb A, Cunningham D, Scarffe JH, et al. Randomized trial comparing epirubicin, eisplatin, and fluorouraeil versus fluorouraeil, doxorubiein, and methotrexate in advanced esophagogastric cancer [J]. J Clin Oncol, 1997,15 ( 1 ) : 261-267.

共引文献163

同被引文献28

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部